Home
RGEN
RGEN News

Latest Repligen Corporation (RGEN) News on February 23, 2025

Morningstar Research

a day ago

Analyst Report: Repligen Corporation

Repligen's Q4 Earnings Beat Estimates, Revenues In Line

Zacks

a day ago

Repligen's Q4 Earnings Beat Estimates, Revenues In Line

MT Newswires

2 days ago

RBC Raises Price Target on Repligen to $205 From $203, Keeps Outperform Rating

MT Newswires

2 days ago

Deutsche Bank Adjusts Repligen Price Target to $195 From $190, Maintains Buy Rating

Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

2 days ago

Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

2 days ago

Q4 2024 Repligen Corp Earnings Call

Morningstar Research

2 days ago

Analyst Report: Repligen Corporation

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

Benzinga

2 days ago

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook

February 2025's US Stocks That May Be Trading Below Fair Value

Simply Wall St.

3 days ago

February 2025's US Stocks That May Be Trading Below Fair Value

What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings

GuruFocus.com

3 days ago

What To Expect From Repligen Corp (RGEN) Q4 2024 Earnings

Repligen (RGEN) Beats Q4 Earnings Estimates

Zacks

3 days ago

Repligen (RGEN) Beats Q4 Earnings Estimates

Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates

StockStory

3 days ago

Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates

Associated Press Finance

3 days ago

Repligen: Q4 Earnings Snapshot

MT Newswires

3 days ago

Repligen Q4 Adjusted Earnings Decline, Revenue Increases -- Shares Up Pre-Bell

Repligen Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

3 days ago

Repligen Reports Fourth Quarter and Full Year 2024 Financial Results

Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow

StockStory

4 days ago

Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow

Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 80% Above Its Share Price

Simply Wall St.

5 days ago

Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 80% Above Its Share Price

Morningstar Research

10 days ago

Analyst Report: Repligen Corporation

3 Healthcare Stocks Skating on Thin Ice

StockStory

10 days ago

3 Healthcare Stocks Skating on Thin Ice

Repligen to Report Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

12 days ago

Repligen to Report Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

13 days ago

TD Cowen Initiates Repligen at Buy With $200 Price Target

Argus Research

18 days ago

RGEN: Rating increased to a HOLD

MT Newswires

19 days ago

RBC Trims Price Target on Repligen to $203 From $207, Keeps Outperform Rating

HRMY vs. RGEN: Which Stock Is the Better Value Option?

Zacks

23 days ago

HRMY vs. RGEN: Which Stock Is the Better Value Option?

Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains?

Zacks

25 days ago

Repligen (RGEN) Surges 3.7%: Is This an Indication of Further Gains?

Argus Research

25 days ago

RGEN: Raising target price to $147.00

Argus Research

a month ago

RGEN: Raising target price to $144.00

Argus Research

a month ago

RGEN: Raising target price to $139.00

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Zacks

a month ago

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Morningstar Research

a month ago

Analyst Report: Repligen Corporation

3 US Stocks Including Advanced Energy Industries That May Be Priced Below Estimated Value

Simply Wall St.

a month ago

3 US Stocks Including Advanced Energy Industries That May Be Priced Below Estimated Value

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 months ago

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Repligen Launches the CTech™ SoloVPE® PLUS System

GlobeNewswire

2 months ago

Repligen Launches the CTech™ SoloVPE® PLUS System

Argus Research

2 months ago

RGEN: Lowering target price to $131.00

Repligen Corporation (RGEN) Fell Along with Peers

Insider Monkey

2 months ago

Repligen Corporation (RGEN) Fell Along with Peers

Morningstar Research

2 months ago

Analyst Report: Repligen Corporation

Argus Research

2 months ago

RGEN: Raising target price to $140.00

Morningstar Research

2 months ago

Analyst Report: Repligen Corporation

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

PR Newswire

2 months ago

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue?

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

GlobeNewswire

2 months ago

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

Argus Research

2 months ago

RGEN: Raising target price to $137.00

Several Factors Lifted Repligen Corporation (RGEN) in Q3

Insider Monkey

2 months ago

Several Factors Lifted Repligen Corporation (RGEN) in Q3

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns

GlobeNewswire

2 months ago

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns

MT Newswires

2 months ago

RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating

Argus Research

3 months ago

RGEN: Raising target price to $134.00

Argus Research

3 months ago

RGEN: Raising target price to $132.00

3 US Stocks Estimated To Be Trading At Discounts Up To 49.1%

Simply Wall St.

3 months ago

3 US Stocks Estimated To Be Trading At Discounts Up To 49.1%

MT Newswires

3 months ago

Repligen Insider Sold Shares Worth $3,386,439, According to a Recent SEC Filing

MT Newswires

3 months ago

Wolfe Research Initiates Repligen at Peer Perform

MT Newswires

3 months ago

UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating

Morningstar Research

3 months ago

Analyst Report: Repligen Corporation

Company News for Nov 13, 2024

Zacks

3 months ago

Company News for Nov 13, 2024

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Repligen Corp Earnings Call

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

3 months ago

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Argus Research

3 months ago

RGEN: Raising target price to $134.00

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

Zacks

3 months ago

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

MT Newswires

3 months ago

Top Midday Gainers

Repligen Stock Soars 10% on Record Growth and Bold Moves

GuruFocus.com

3 months ago

Repligen Stock Soars 10% on Record Growth and Bold Moves

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates

Zacks

3 months ago

Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates

MT Newswires

3 months ago

Sector Update: Health Care

MT Newswires

3 months ago

Repligen Q3 Adjusted Earnings, Revenue Rise; 2024 Guidance Updated

Associated Press Finance

3 months ago

Repligen: Q3 Earnings Snapshot

Repligen Reports Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Repligen Reports Third Quarter 2024 Financial Results

Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings

GuruFocus.com

3 months ago

Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings

Argus Research

4 months ago

RGEN: Raising target price to $121.00

Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewswire

4 months ago

Repligen Corporation to Present at Upcoming Investor Conferences

Repligen to Report Third Quarter 2024 Financial Results

GlobeNewswire

4 months ago

Repligen to Report Third Quarter 2024 Financial Results

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

4 months ago

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Zacks

4 months ago

Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release

US Stocks Estimated Below Intrinsic Value In October 2024

Simply Wall St.

4 months ago

US Stocks Estimated Below Intrinsic Value In October 2024

3 investable themes, categories outside of the AI trade

Yahoo Finance Video

4 months ago

3 investable themes, categories outside of the AI trade

Argus Research

4 months ago

RGEN: Lowering target price to $116.00

Morningstar Research

5 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Morningstar Research

5 months ago

Analyst Report: Repligen Corporation

MT Newswires

5 months ago

Repligen Opens Training & Innovation Center

Repligen Opens Training & Innovation Center to Elevate Customer Experience

GlobeNewswire

5 months ago

Repligen Opens Training & Innovation Center to Elevate Customer Experience

MT Newswires

5 months ago

Repligen to Restate Financial Results on COVID-Related Payment Cancellation

MT Newswires

5 months ago

RBC Raises Price Target on Repligen to $205 From $190, Keeps Outperform Rating

Several Headwinds Dragged Repligen Corporation (RGEN) in Q2

Insider Monkey

5 months ago

Several Headwinds Dragged Repligen Corporation (RGEN) in Q2

Reasons for the Decline of Repligen (RGEN) in Q2

Insider Monkey

5 months ago

Reasons for the Decline of Repligen (RGEN) in Q2

Repligen Corporation (RGEN) Fell Due to CEO Transition

Insider Monkey

6 months ago

Repligen Corporation (RGEN) Fell Due to CEO Transition

Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?

Zacks

6 months ago

Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?

Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate

Simply Wall St.

6 months ago

Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate

Argus Research

6 months ago

RGEN: Lowering target price to $117.00

Repligen Corporation (RGEN) Benefitted From Drug Approval

Insider Monkey

6 months ago

Repligen Corporation (RGEN) Benefitted From Drug Approval

Repligen Corporation to Present at Wells Fargo Healthcare Conference

GlobeNewswire

6 months ago

Repligen Corporation to Present at Wells Fargo Healthcare Conference

Argus Research

6 months ago

RGEN: Lowering target price to $126.00

MT Newswires

6 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

6 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

6 months ago

Sector Update: Health Care

MT Newswires

6 months ago

Market Chatter: Maravai LifeSciences Receives Acquisition Offer From Repligen

Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?

Insider Monkey

6 months ago

Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?

MT Newswires

7 months ago

Repligen Insider Sold Shares Worth $1,139,016, According to a Recent SEC Filing

Here's Why Shares in This Hot Healthcare Stock Surged This Week

Motley Fool

7 months ago

Here's Why Shares in This Hot Healthcare Stock Surged This Week

3 US Stocks Estimated To Be Undervalued By Up To 40.1%

Simply Wall St.

7 months ago

3 US Stocks Estimated To Be Undervalued By Up To 40.1%

Repligen Second Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

7 months ago

Repligen Second Quarter 2024 Earnings: EPS Misses Expectations

MT Newswires

7 months ago

UBS Lowers Repligen's Price Target to $185 From $205, Buy Rating Maintained

Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates

Zacks

7 months ago

Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates

Share on Social Networks: